ERNEST MARIO

CIK 1180469 · last filed 2024-06-10

ERNEST MARIO is a corporate insider who has filed 301 SEC Form 4 insider transactions across 15 companies since 2007. The most recent filing, for SLNO, was dated Jun 10, 2024. Across all open-market trades the lifetime net is −$44.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $12.7M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$12.68M

Companies

15

Total Filings

301

Lifetime Open-Market Net

-$44.39M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SLNO Director 214,855 $53.01 $11.39M $0 20 2024-06-10
HYPERION DEFI, INC. (EYEN) Delisted Director 382,706 $15.82 $6.05M $1.19M 8 2021-11-22
Kindred Biosciences, Inc. (KIN) Delisted Director 125,000 $9.25 $1.16M $387.0K 14 2021-01-22
CELGENE CORP /DE/ (CELGZ) Delisted Director 0 -$26.01M 51 2019-11-22
SOLENO THERAPEUTICS INC (SLNOW) Delisted Director 471,218 $0 12 2019-06-12
TNXP Director 113,822 $11.35 $1.29M $1.03M 30 2018-06-27
CHIMERIX INC (CMRX) Delisted Director 121,072 $8.54 $1.03M $1.22M 36 2018-05-21
SOLENO THERAPEUTICS INC (CAPNW) Delisted Director 1,795,929 $0 2 2017-05-09
SOLENO THERAPEUTICS INC (CAPN.W) Delisted Director 1,789,678 $522.7K 20 2016-10-11
BOSTON SCIENTIFIC CORP (BSXw) Delisted Director 86,032 -$4.09M 47 2015-11-17
XENOPORT INC (XNPT) Delisted Director 88,750 $194.8K 6 2015-05-21
VIVUS INC (VVUS) Delisted Director 81,125 $758.9K 5 2013-05-30
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI) Delisted Director 0 -$20.28M 31 2011-12-06
CELGENE CORP /DE/ (CELG) Delisted Director 23,185 $687.4K 9 2010-06-18
Alexza Pharmaceuticals Inc. (ALXA) Delisted Director 18,181 $0 2 2007-07-26

Recent Filings

301 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2024-06-10 SLNO Grant (A) +6,500 $0 EDGAR
2024-05-23 SLNO Exer (X) +62,000 $279.0K EDGAR
2024-01-10 SLNO Gift (G) −3,523 $0 EDGAR
2023-12-04 SLNO Gift (G) −8,700 $0 EDGAR
2023-05-26 SLNO Grant (A) $0 EDGAR
2022-10-14 SLNO $0 EDGAR
2022-10-14 SLNO Grant (A) $0 EDGAR
2022-04-04 SLNO Buy (P) +1,860,000 $0 EDGAR
2022-02-02 SLNO Grant (A) +56,338 $20.0K EDGAR
2021-11-22 HYPERION DEFI, INC. (EYEN) Delisted Grant (A) +6,963 $0 EDGAR
Showing 110 of 301
Page 1 of 31
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.